Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ZENSARTECH.NS Stock Summary
Top 10 Correlated ETFs
ZENSARTECH.NS
In the News
ZENSARTECH.NS Financial details
Company Rating
Neutral
Market Cap
133.74B
Income
6.11B
Revenue
48.85B
Book val./share
-
Cash/share
-
Dividend
5
Dividend %
0.88%
Employees
7.8K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
24.34
Forward P/E
21.98
PEG
5.25
P/S
2.62
P/B
3.93
P/C
-
P/FCF
895.16
Quick Ratio
1.97
Current Ratio
2.95
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
26.98
EPS next Y
27.61
EPS next Q
6.4
EPS this Y
-21.49%
EPS next Y
2.34%
EPS next 5Y
17.41%
EPS last 5Y
0.76%
Revenue last 5Y
4.1%
Revenue Q/Q
-2.96%
EPS Q/Q
-7.03%
-
-
-
-
SMA20
9.7%
SMA50
3.34%
SMA100
19.27%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
34%
ROC
0.2%
Gross Margin
22%
Oper. Margin
14%
Profit Margin
11%
Payout
-
Shs Outstand
226.57M
Shs Float
107.46M
-
-
-
-
Target Price
-
52W Range
258.8-644.0
52W High
-5.78%
52W Low
+135.17%
RSI
65
Rel Volume
1.09
Avg Volume
1.33M
Volume
1.45M
Perf Week
3.98%
Perf Month
16.68%
Perf Quarter
14.44%
Perf Half Y
14.42%
-
-
-
-
Beta
0.897
-
-
Volatility
11.6%, 25.19%
Prev Close
-0.01%
Price
606.75
Change
0.09%
ZENSARTECH.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 176.23 | 185.63 | 167.72 | 187.88 | 214.18 | |
Net income per share | 13.93 | 11.69 | 13.31 | 18.43 | 14.47 | |
Operating cash flow per share | 6.93 | 30.46 | 38.06 | 14.82 | 31.56 | |
Free cash flow per share | 4.6 | 26.99 | 36.3 | 12.3 | 29.93 | |
Cash per share | 16.39 | 34.68 | 46.91 | 45.32 | 52 | |
Book value per share | 86.3 | 92.78 | 103.89 | 118.95 | 131.48 | |
Tangible book value per share | 49.14 | 54.93 | 72.14 | 78.95 | 94.05 | |
Share holders equity per share | 86.3 | 92.78 | 103.89 | 118.95 | 131.48 | |
Interest debt per share | 14.66 | 35.6 | 17.39 | 16.38 | 13.29 | |
Market cap | 51.9B | 19.82B | 61.76B | 82.89B | 62.1B | |
Enterprise value | 51.73B | 22.44B | 61.77B | 81.19B | 60.09B | |
P/E ratio | 16.55 | 7.53 | 20.59 | 19.91 | 18.96 | |
Price to sales ratio | 1.31 | 0.47 | 1.63 | 1.95 | 1.28 | |
POCF ratio | 33.26 | 2.89 | 7.2 | 24.76 | 8.69 | |
PFCF ratio | 50.1 | 3.26 | 7.55 | 29.83 | 9.17 | |
P/B Ratio | 2.67 | 0.95 | 2.64 | 3.08 | 2.09 | |
PTB ratio | 2.67 | 0.95 | 2.64 | 3.08 | 2.09 | |
EV to sales | 1.3 | 0.54 | 1.63 | 1.91 | 1.24 | |
Enterprise value over EBITDA | 9.46 | 3.61 | 8.2 | 10.23 | 9.17 | |
EV to operating cash flow | 33.16 | 3.27 | 7.2 | 24.26 | 8.41 | |
EV to free cash flow | 49.94 | 3.69 | 7.55 | 29.21 | 8.87 | |
Earnings yield | 0.06 | 0.13 | 0.05 | 0.05 | 0.05 | |
Free cash flow yield | 0.02 | 0.31 | 0.13 | 0.03 | 0.11 | |
Debt to equity | 0.15 | 0.36 | 0.15 | 0.12 | 0.09 | |
Debt to assets | 0.1 | 0.21 | 0.1 | 0.09 | 0.07 | |
Net debt to EBITDA | -0.03 | 0.42 | 0 | -0.21 | -0.31 | |
Current ratio | 2.04 | 1.98 | 2.7 | 2.73 | 2.7 | |
Interest coverage | 14.03 | 6.78 | 12.2 | 14.97 | 13.24 | |
Income quality | 0.35 | 1.83 | 1.78 | 0.58 | 1.61 | |
Dividend Yield | 0.01 | 0.06 | 0 | 0.01 | 0.02 | |
Payout ratio | 0.2 | 0.45 | 0.09 | 0.21 | 0.35 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.28 | 0.24 | 0.22 | 0.23 | 0.21 | |
Capex to operating cash flow | -0.34 | -0.11 | -0.05 | -0.17 | -0.05 | |
Capex to revenue | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.59 | -0.49 | -0.23 | -0.31 | -0.2 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 164.49 | 156.24 | 176.36 | 222.1 | 206.92 | |
ROIC | 0.13 | 0.08 | 0.12 | 0.11 | 0.08 | |
Return on tangible assets | 0.14 | 0.1 | 0.11 | 0.14 | 0.1 | |
Graham Net | 16.98 | 10.32 | 20.7 | 27.97 | 30.59 | |
Working capital | 9.87B | 10.18B | 12.54B | 14.33B | 14.6B | |
Tangible asset value | 11.06B | 12.37B | 16.27B | 17.83B | 21.29B | |
Net current asset value | 8.08B | 5.76B | 9.3B | 10.79B | 11.74B | |
Invested capital | 0.15 | 0.36 | 0.15 | 0.12 | 0.09 | |
Average receivables | 12.41B | 13.2B | 10.23B | 10.15B | 11.12B | |
Average payables | 2.42B | 2.83B | 2.43B | 2.68B | 2.97B | |
Average inventory | 1.02B | 962.9M | -1.29B | -2.58B | -2.16B | |
Days sales outstanding | 134.28 | 103.11 | 83.37 | 100.26 | 79.68 | |
Days payables outstanding | 36.73 | 30.13 | 29.8 | 36.71 | 25.55 | |
Days of inventory on hand | 12.02 | 10.7 | -47.81 | -18.98 | -24.65 | |
Receivables turnover | 2.72 | 3.54 | 4.38 | 3.64 | 4.58 | |
Payables turnover | 9.94 | 12.12 | 12.25 | 9.94 | 14.29 | |
Inventory turnover | 30.38 | 34.11 | -7.63 | -19.23 | -14.81 | |
ROE | 0.16 | 0.13 | 0.13 | 0.15 | 0.11 | |
Capex per share | -2.33 | -3.47 | -1.75 | -2.51 | -1.63 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 52.91 | 53.51 | 54.21 | 54.8 | 53.17 | |
Net income per share | 3.38 | 5.26 | 6.9 | 7.68 | 7.14 | |
Operating cash flow per share | 4.39 | 0.63 | 3.74 | 3.23 | 2.76 | |
Free cash flow per share | 4.39 | 0.63 | 3.74 | 3.23 | 2.76 | |
Cash per share | 58.26 | 51.95 | 51.79 | 77.87 | 0 | |
Book value per share | 122.13 | 131.34 | 131.47 | 143.61 | 0 | |
Tangible book value per share | 0 | 93.95 | 0 | 107.24 | 0 | |
Share holders equity per share | 122.13 | 131.34 | 131.47 | 143.61 | 0 | |
Interest debt per share | 0.34 | 12.33 | 0.27 | 10.98 | 0.28 | |
Market cap | 48.21B | 62.17B | 87.6B | 117.16B | 137.51B | |
Enterprise value | 61.39B | 60.15B | 99.32B | 114.78B | 137.51B | |
P/E ratio | 15.75 | 13.04 | 14.02 | 16.84 | 21.26 | |
Price to sales ratio | 4.03 | 5.13 | 7.14 | 9.44 | 11.42 | |
POCF ratio | 48.5 | 434.74 | 103.54 | 160.05 | 220.37 | |
PFCF ratio | 48.5 | 434.74 | 103.54 | 160.05 | 220.37 | |
P/B Ratio | 1.74 | 2.09 | 2.94 | 3.6 | 0 | |
PTB ratio | 1.74 | 2.09 | 2.94 | 3.6 | 0 | |
EV to sales | 5.13 | 4.96 | 8.09 | 9.25 | 11.42 | |
Enterprise value over EBITDA | 38.18 | 29.63 | 38.42 | 42.96 | 55.07 | |
EV to operating cash flow | 61.77 | 420.66 | 117.4 | 156.8 | 220.37 | |
EV to free cash flow | 61.77 | 420.66 | 117.4 | 156.8 | 220.37 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Free cash flow yield | 0.02 | 0 | 0.01 | 0.01 | 0 | |
Debt to equity | 0 | 0.09 | 0 | 0.07 | 0 | |
Debt to assets | 0 | 0.07 | 0 | 0.06 | 0 | |
Net debt to EBITDA | 8.2 | -0.99 | 4.54 | -0.89 | 0 | |
Current ratio | 0 | 2.7 | 0 | 2.95 | 0 | |
Interest coverage | 14.62 | 26.23 | 31.3 | 40.46 | 34.14 | |
Income quality | 1.3 | 0.12 | 0.54 | 0.42 | 0.39 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.06 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.21 | 0 | 0.19 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Graham number | 96.37 | 124.68 | 142.87 | 157.53 | 0 | |
ROIC | 0.03 | 0.04 | 0.05 | 0.05 | 0 | |
Return on tangible assets | 0 | 0.04 | 0 | 0.05 | 0 | |
Graham Net | 58.26 | 30.55 | 51.79 | 50.96 | 0 | |
Working capital | 13.19B | 14.6B | 11.73B | 17.46B | 0 | |
Tangible asset value | 0 | 21.29B | 0 | 24.28B | 0 | |
Net current asset value | 13.19B | 11.74B | 11.73B | 14.9B | 0 | |
Invested capital | 0 | 0.09 | 0 | 0.07 | 0 | |
Average receivables | 3.6B | 5.29B | 5.29B | 3.6B | 3.6B | |
Average payables | 1.52B | 1.39B | 1.39B | 1.56B | 1.56B | |
Average inventory | 0 | -1.34B | -1.34B | 0 | 0 | |
Days sales outstanding | 0 | 78.56 | 0 | 52.23 | 0 | |
Days payables outstanding | 0 | 26.23 | 0 | 30.04 | 0 | |
Days of inventory on hand | 0 | -25.31 | 0 | 0 | 0 | |
Receivables turnover | 0 | 1.15 | 0 | 1.72 | 0 | |
Payables turnover | 0 | 3.43 | 0 | 3 | 0 | |
Inventory turnover | 0 | -3.56 | 0 | 0 | 0 | |
ROE | 0.03 | 0.04 | 0.05 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ZENSARTECH.NS Frequently Asked Questions
What is Zensar Technologies Limited stock symbol ?
Zensar Technologies Limited is a IN stock and trading under the symbol ZENSARTECH.NS
What is Zensar Technologies Limited stock quote today ?
Zensar Technologies Limited stock price is $606.75 today.
Is Zensar Technologies Limited stock public?
Yes, Zensar Technologies Limited is a publicly traded company.